Published in J Clin Pharmacol on February 09, 2010
Breastfeeding and migraine drugs. Eur J Clin Pharmacol (2014) 0.78
Breastfeeding and the use of human milk. American Academy of Pediatrics. Work Group on Breastfeeding. Pediatrics (1997) 8.53
Transfer of drugs and other chemicals into human milk. Pediatrics (2001) 4.17
Toxic effects of atenolol consumed during breast feeding. J Pediatr (1989) 2.11
Breastfeeding is analgesic in healthy newborns. Pediatrics (2002) 1.40
Pregnancy-induced increase in metoprolol metabolism. Clin Pharmacol Ther (1985) 1.30
24-hour creatinine clearance during the third trimester of normal pregnancy. Br J Obstet Gynaecol (1980) 1.27
Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction. J Pharmacol Exp Ther (2002) 1.24
Prolactin release during nursing and breast stimulation in postpartum and nonpostpartum subjects. J Clin Endocrinol Metab (1974) 1.15
Human lactational and ovarian response to endogenous prolactin release. Science (1972) 1.11
Effect of breast-feeding on pain relief during infant immunization injections. Int J Nurs Pract (2009) 1.08
Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol (2005) 1.05
Drug excretion into breast milk--overview. Adv Drug Deliv Rev (2003) 1.04
The use of breast-feeding for pain relief during neonatal immunization injections. Appl Nurs Res (2007) 0.98
Involvement of influx and efflux transport systems in gastrointestinal absorption of celiprolol. J Pharm Sci (2009) 0.89
Atenolol elimination in the neonate. Br J Clin Pharmacol (1983) 0.88
Pharmacologic management of supraventricular tachycardias in children. Part 2: Atrial flutter, atrial fibrillation, and junctional and atrial ectopic tachycardia. Ann Pharmacother (1997) 0.84
Hyperprolactinemia influences renal function in man. Metabolism (1976) 0.83
Serum levels of prolactin and milk production in women during a lactation period of thirty months. Clin Endocrinol (Oxf) (1981) 0.83
Renal functional reserve in pregnancy. Nephrol Dial Transplant (1988) 0.83
Long-term efficacy and safety of atenolol for supraventricular tachycardia in children. Pediatr Cardiol (1997) 0.81
Atenolol in children with supraventricular tachycardia. Am J Cardiol (1989) 0.80
Atenolol and metoprolol. A comparison of their excretion into human breast milk. Acta Obstet Gynecol Scand Suppl (1984) 0.80
Increased oral clearance of metoprolol in pregnancy. Eur J Clin Pharmacol (1983) 0.80
Toxic effects of atenolol consumed during breast feeding. J Pediatr (1989) 0.78
Renal effects of recombinant prolactin in anaesthetized rats. Eur J Endocrinol (2001) 0.78
Levels of the beta-blockers atenolol and propranolol in the breast milk of women treated for hypertension in pregnancy. Biopharm Drug Dispos (1983) 0.77
Atenolol in human plasma and breast milk. Obstet Gynecol (1984) 0.77
Essential hypertension and pregnancy: successful outcome with atenolol. Br J Clin Pract (1984) 0.77
The reporting of pre-existing maternal medical conditions and complications of pregnancy on birth certificates and in hospital discharge data. Am J Obstet Gynecol (2005) 3.20
Magnesium sulfate for neuroprotection after traumatic brain injury: a randomised controlled trial. Lancet Neurol (2007) 2.68
Accuracy of reporting maternal in-hospital diagnoses and intrapartum procedures in Washington State linked birth records. Paediatr Perinat Epidemiol (2005) 2.37
Acetoacetate, acetone, and dibenzylamine (a contaminant in l-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo. Epilepsia (2002) 1.82
A report of dizygous monochorionic twins. N Engl J Med (2003) 1.73
Validity of maternal and perinatal risk factors reported on fetal death certificates. Am J Public Health (2005) 1.45
Pharmacokinetics of oseltamivir among pregnant and nonpregnant women. Am J Obstet Gynecol (2011) 1.36
The breast cancer resistance protein (Bcrp1/Abcg2) limits fetal distribution of glyburide in the pregnant mouse: an Obstetric-Fetal Pharmacology Research Unit Network and University of Washington Specialized Center of Research Study. Mol Pharmacol (2007) 1.26
Profiling gene expression in human placentae of different gestational ages: an OPRU Network and UW SCOR Study. Reprod Sci (2008) 1.25
Pharmacology and placental transport of 17-hydroxyprogesterone caproate in singleton gestation. Am J Obstet Gynecol (2012) 1.22
Effect of CYP3A5 polymorphism on tacrolimus metabolic clearance in vitro. Drug Metab Dispos (2006) 1.22
Impact of police-reported intimate partner violence during pregnancy on birth outcomes. Obstet Gynecol (2003) 1.18
An inducible cytochrome P450 3A4-dependent vitamin D catabolic pathway. Mol Pharmacol (2011) 1.18
Nicotinamide treatment reduces behavioral impairments and provides cortical protection after fluid percussion injury in the rat. J Neurotrauma (2006) 1.10
Pharmacokinetics of metformin during pregnancy. Drug Metab Dispos (2010) 1.09
Police-reported intimate partner violence during pregnancy and the risk of antenatal hospitalization. Matern Child Health J (2004) 1.08
The status of pharmacometrics in pregnancy: highlights from the 3(rd) American conference on pharmacometrics. Br J Clin Pharmacol (2012) 1.07
In vitro metabolism of cyclosporine A by human kidney CYP3A5. Biochem Pharmacol (2004) 1.06
Pharmacokinetics and pharmacodynamics of atenolol during pregnancy and postpartum. J Clin Pharmacol (2005) 1.05
Simultaneous measurement of plasma vitamin D(3) metabolites, including 4β,25-dihydroxyvitamin D(3), using liquid chromatography-tandem mass spectrometry. Anal Biochem (2011) 1.04
Cardiovascular and thromboembolic events following hypertensive pregnancy. Am J Kidney Dis (2003) 0.99
Induction of labor in the absence of standard medical indications: incidence and correlates. Med Care (2007) 0.98
Optimal prevention of seizures induced by high-dose busulfan. Pharmacotherapy (2008) 0.98
Cyclosporin A, tacrolimus and sirolimus are potent inhibitors of the human breast cancer resistance protein (ABCG2) and reverse resistance to mitoxantrone and topotecan. Cancer Chemother Pharmacol (2006) 0.97
Sustained delivery of nicotinamide limits cortical injury and improves functional recovery following traumatic brain injury. Oxid Med Cell Longev (2010) 0.97
The effect of valproic acid on drug and steroid glucuronidation by expressed human UDP-glucuronosyltransferases. Biochem Pharmacol (2003) 0.97
Contributions of human cytochrome P450 enzymes to glyburide metabolism. Biopharm Drug Dispos (2010) 0.96
Creating a network of high-quality skilled nursing facilities: preliminary data on the postacute care quality improvement experiences of an accountable care organization. J Am Geriatr Soc (2015) 0.96
CYP2D6 mediates 4-hydroxylation of clonidine in vitro: implication for pregnancy-induced changes in clonidine clearance. Drug Metab Dispos (2010) 0.95
Role of cytochrome P450 2C8 and 2J2 genotypes in calcineurin inhibitor-induced chronic kidney disease. Pharmacogenet Genomics (2008) 0.95
Changes in maternal liver Cyp2c and Cyp2d expression and activity during rat pregnancy. Biochem Pharmacol (2008) 0.93
Pioglitazone: effect on CYP3A4 activity. J Clin Pharmacol (2002) 0.92
Simultaneous PET imaging of P-glycoprotein inhibition in multiple tissues in the pregnant nonhuman primate. J Nucl Med (2009) 0.91
Interpreting tacrolimus concentrations during pregnancy and postpartum. Transplantation (2013) 0.91
Detecting small for gestational age infants: the development of a population-based reference for Washington state. Am J Perinatol (2005) 0.91
A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med (2008) 0.90
Drug-drug interactions involving membrane transporters in the human kidney. Expert Opin Drug Metab Toxicol (2006) 0.90
Gestational age-dependent changes in gene expression of metabolic enzymes and transporters in pregnant mice. Drug Metab Dispos (2012) 0.90
Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. Br J Clin Pharmacol (2013) 0.89
Maternal hemodynamic changes associated with furosemide treatment. Hypertens Pregnancy (2007) 0.89
A sister's risk: family history as a predictor of preeclampsia. Am J Obstet Gynecol (2005) 0.88
Validation of a sensitive LC-MS assay for quantification of glyburide and its metabolite 4-transhydroxy glyburide in plasma and urine: an OPRU Network study. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.88
Pharmacokinetic of antiepileptic drugs in patients with hepatic or renal impairment. Clin Pharmacokinet (2014) 0.88
Police-reported intimate partner violence during pregnancy: who is at risk? Violence Vict (2005) 0.88
Continuous nicotinamide administration improves behavioral recovery and reduces lesion size following bilateral frontal controlled cortical impact injury. Behav Brain Res (2011) 0.87
A comparison of the effects of nicotinamide and progesterone on functional recovery of cognitive behavior following cortical contusion injury in the rat. J Neurotrauma (2012) 0.87
Zinc protoporphyrin/heme as an indicator of iron status in NICU patients. J Pediatr (2003) 0.87
Diabetic nephropathy in pregnancy: suboptimal hypertensive control associated with preterm delivery. Am J Hypertens (2006) 0.87
Hemodynamically-directed atenolol therapy is associated with a blunted rise in maternal sFLT-1 levels during pregnancy. Hypertens Pregnancy (2009) 0.87
Nifedipine pharmacokinetics are influenced by CYP3A5 genotype when used as a preterm labor tocolytic. Am J Perinatol (2012) 0.87
Gestational diabetes or lesser degrees of glucose intolerance and risk of preeclampsia. Hypertens Pregnancy (2010) 0.87
Maternal, perinatal, and postneonatal outcomes in women with chronic heart disease in Washington State. Obstet Gynecol (2012) 0.86
Where is the evidence that p-glycoprotein limits brain uptake of antiepileptic drug and contributes to drug resistance in epilepsy? Epilepsia (2007) 0.86
Pharmacokinetics of tacrolimus during pregnancy. Ther Drug Monit (2012) 0.86
The red blood cell participates in regulation of the circulation by producing and releasing epoxyeicosatrienoic acids. Prostaglandins Other Lipid Mediat (2011) 0.85
Increased glyburide clearance in the pregnant mouse model. Drug Metab Dispos (2010) 0.85
Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters. Drug Metab Dispos (2006) 0.85
Effect of gestational age on mRNA and protein expression of polyspecific organic cation transporters during pregnancy. Drug Metab Dispos (2013) 0.85
Red blood cells (RBCs), epoxyeicosatrienoic acids (EETs) and adenosine triphosphate (ATP). Pharmacol Rep (2010) 0.84
Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens (2010) 0.84
Is ethnicity associated with morphine's side effects in children? Morphine pharmacokinetics, analgesic response, and side effects in children having tonsillectomy. Paediatr Anaesth (2012) 0.84
Repeat cesarean delivery: what indications are recorded in the medical chart? Birth (2006) 0.83
Physiologically based pharmacokinetic model of midazolam disposition during pregnancy. Conf Proc IEEE Eng Med Biol Soc (2008) 0.83
A pharmacologic approach to the use of glyburide in pregnancy. Obstet Gynecol (2013) 0.82
Ketorolac tromethamine: stereo-specific pharmacokinetics and single-dose use in postoperative infants aged 2-6 months. Paediatr Anaesth (2010) 0.82
Rufinamide: a new anti-epileptic medication. Expert Opin Pharmacother (2007) 0.81
CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition. Transplantation (2013) 0.81
The impact of duration of labor induction on cesarean rate. Am J Obstet Gynecol (2008) 0.81
Voltage-dependent block of N-methyl-D-aspartate receptors by the novel anticonvulsant dibenzylamine, a bioactive constituent of L-(+)-beta-hydroxybutyrate. Epilepsia (2003) 0.81
Postoperative ketorolac tromethamine use in infants aged 6-18 months: the effect on morphine usage, safety assessment, and stereo-specific pharmacokinetics. Anesth Analg (2007) 0.81
Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci (2011) 0.80
Pharmacotherapy and pregnancy: highlights from the Second International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci (2009) 0.80
Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations. Clin Pharmacokinet (2002) 0.79
Ginkgo biloba: evaluation of CYP2C9 drug interactions in vitro and in vivo. Am J Ther (2006) 0.79
Pharmacokinetic and pharmacodynamic drug interactions with ethanol (alcohol). Clin Pharmacokinet (2014) 0.78
Digoxin therapy and the risk of primary cardiac arrest in patients with congestive heart failure: effect of mild-moderate renal impairment. J Clin Epidemiol (2003) 0.78
Pharmacokinetics of doxorubicin in pregnant women. Cancer Chemother Pharmacol (2014) 0.78
Inhaled beta-2 adrenergic receptor agonists and primary cardiac arrest. Am J Med (2002) 0.77
Comparison of the effect of minocycline and simvastatin on functional recovery and gene expression in a rat traumatic brain injury model. J Neurotrauma (2014) 0.77
Magnesium for neuroprotection after traumatic brain injury. Lancet Neurol (2007) 0.77
Effects of cranberry juice on pharmacokinetics of beta-lactam antibiotics following oral administration. Antimicrob Agents Chemother (2009) 0.77
Valproic acid, but not lamotrigine, suppresses seizure-induced c-fos and c-Jun mRNA expression. Brain Res Mol Brain Res (2005) 0.77
Transiently altered acetaminophen metabolism after liver transplantation. Clin Pharmacol Ther (2003) 0.77
Fuzzy images: Ethical implications of using routine neuroimaging in premature neonates to predict neurologic outcomes. J Pediatr (2013) 0.76
Duration of cisplatin excretion in breast milk. J Hum Lact (2013) 0.76
Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide. Ther Clin Risk Manag (2009) 0.75
Position statement on the coverage of anticonvulsant drugs for the treatment of epilepsy: what's the problem with generic antiepileptic drugs? A call to action. Neurology (2007) 0.75